NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
ObjectiveThis meta-analysis aimed to investigate the effects of glucocerebrosidase gene (GBA) variations on the risk of Parkinson's disease dementia (PDD) and to identify the relationship between GBA variations and PDD.MethodA comprehensive search was performed to retrieve publications from PubMed, Cochrane Library, Embase and Web of Science up to March 19, 2025. The search terms included "glucocerebrosidase," "Parkinson's disease," and "dementia." After rigorous screening, cohort studies were included for meta-analysis.ResultsThis meta-analysis revealed a significant overall association between the presence of GBA variation and an increased risk of dementia in PD patients (RR = 1.82, 95% CI: 1.52-2.18, p p p = 0.001). Analysis of specific mutations revealed that the N370S variant was associated with an increase in dementia risk (RR = 1.54, 95% CI: 1.24-1.92, p p p ConclusionGBA variations are significant risk factors for PDD, with varying degrees of risk conferred by different variants. These findings underscore the critical role of GBA in the pathogenesis of PDD and highlight its potential as a key genetic risk factor.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/display_record.php?, Identifier CRD420251109378.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.